Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian L Harris

Showing results (211-220 of 464) with videos related to

Pageof 47
Sort By:
Breast Cancer Research and Treatment|November 21, 2007
Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomasGaynor J Bates, Stephen B Fox, Cheng Han, et al.
BMC Cancer|August 6, 2021
Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugsEsther Arnaiz, Ana Miar, Esther Bridges, et al.
The Journal of Pathology|July 13, 2002
Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2Mária Bartosová, Seppo Parkkila, Kamil Pohlodek, et al.
Breast Cancer Research : BCR|December 22, 2007
Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancerErn Yu Tan, Leticia Campo, Cheng Han, et al.
Chinese Journal of Cancer|February 14, 2016
Why some tumours trigger neovascularisation and others don't: the story thus farOmanma Adighibe, Russell D Leek, Marta Fernandez-Mercado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapseGaynor J Bates, Stephen B Fox, Cheng Han, et al.
Cells|November 26, 2022
Survival Pathways of HIF-Deficient Tumour Cells: TCA Inhibition, Peroxisomal Fatty Acid Oxidation Activation and an AMPK-PGC-1α Hypoxia SensorMonika A Golinska, Marion Stubbs, Adrian L Harris, et al.
Metabolites|November 29, 2019
ADGRL4/ELTD1 Silencing in Endothelial Cells Induces ACLY and SLC25A1 and Alters the Cellular Metabolic ProfileDavid M Favara, Christos E Zois, Syed Haider, et al.
Nature|October 25, 2008
MicroRNA-10b and breast cancer metastasisHarriet E Gee, Carme Camps, Francesca M Buffa, et al.
Molecular Pharmacology|May 23, 2003
Non-nuclear localized human NOSII enhances the bioactivation and toxicity of tirapazamine (SR4233) in vitroEdwin C Chinje, Rachel L Cowen, Jian Feng, et al.
Pageof 47

Showing results (211-220 of 464) with videos related to

Sort By:
Pageof 47
Breast Cancer Research and Treatment|November 21, 2007
Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomasGaynor J Bates, Stephen B Fox, Cheng Han, et al.
BMC Cancer|August 6, 2021
Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugsEsther Arnaiz, Ana Miar, Esther Bridges, et al.
The Journal of Pathology|July 13, 2002
Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2Mária Bartosová, Seppo Parkkila, Kamil Pohlodek, et al.
Breast Cancer Research : BCR|December 22, 2007
Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancerErn Yu Tan, Leticia Campo, Cheng Han, et al.
Chinese Journal of Cancer|February 14, 2016
Why some tumours trigger neovascularisation and others don't: the story thus farOmanma Adighibe, Russell D Leek, Marta Fernandez-Mercado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapseGaynor J Bates, Stephen B Fox, Cheng Han, et al.
Cells|November 26, 2022
Survival Pathways of HIF-Deficient Tumour Cells: TCA Inhibition, Peroxisomal Fatty Acid Oxidation Activation and an AMPK-PGC-1α Hypoxia SensorMonika A Golinska, Marion Stubbs, Adrian L Harris, et al.
Metabolites|November 29, 2019
ADGRL4/ELTD1 Silencing in Endothelial Cells Induces ACLY and SLC25A1 and Alters the Cellular Metabolic ProfileDavid M Favara, Christos E Zois, Syed Haider, et al.
Nature|October 25, 2008
MicroRNA-10b and breast cancer metastasisHarriet E Gee, Carme Camps, Francesca M Buffa, et al.
Molecular Pharmacology|May 23, 2003
Non-nuclear localized human NOSII enhances the bioactivation and toxicity of tirapazamine (SR4233) in vitroEdwin C Chinje, Rachel L Cowen, Jian Feng, et al.
Pageof 47